PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

North & South Brother Pharmacy Investment Company Limited

USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2019–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, North ranks #26,989 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.

#26,989
of 49,997 US assignees by volume
23rd percentile
by Innovation Score (27.3/100)
17.3
avg claims per patent
+300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26989 · Foreign Corporation #26,989 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #26,989/49,997
  • PHOTO-FINISH NO Screw
  • CPC-NARROW A61K · 6 areas
  • INNOV-THIN 27.3/100
  • CLAIMS-RICH 17.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +300% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: NO Screw Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How North’s 27.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around North

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows North's Innovation Score is 27.3/100 (23rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for North?

Each dot is one of North’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). North’s own 17.3 claims/patent is ABOVE the 17.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

North vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 9.99.91010.1 510152025 Granted patents (volume) Avg claims / patent NO Screw Ltd. - 10, 17.2NO ScrewNOA, Inc. - 10, 18.2NOANoble Drilling A/S - 10, 17.7Noble Drilling A/SNoke, Inc. - 10, 17.7NokeNovabiotics Limited - 10, 12.1NovabioticsNovabone Products, LLC - 10, 23.6Novabone ProductsNovastep - 10, 8.8NovastepNovatron OY - 10, 14.8Novatron OYNorth & South Brother Pharmacy Investment Company Limited - 10, 17.3North & South Bro…
North vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where North's grants concentrate

North & South Brother Pharmacy Investment Company Limited is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (8 grants) versus a trough of 2 in 2019. By volume, North sits between NO Screw Ltd. and Novatron OY.

Who files at North's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows North holds 10 patents at rank #26,944, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near North

By rank, the assignees closest to #26,944 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in North's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for North, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), North ranks #2,196 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (27 here).

Intraway R&D S.A. 27 Bioiberica, S.A.U. 27 Guangzhou ZhiGong Trading Co., Ltd. 27 Heemskerk Vasteplanten BV 27

North's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 23rd percentile higher than 23% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 20192020 8
USPTO utility patent grants by year · 2019–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
North & South Brother Pharmacy Investment Company Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 2 20.0%
2020 8 80.0%

Which technologies does North & South Brother Pharmacy Investment Company Limited patent most?

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

North & South Brother Pharmacy Investment Company Limited's patent record in context - here's where to go next.

  • North & South Brother Pharmacy Investment Company Limited's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #26,989 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare North & South Brother Pharmacy Investment Company Limited against NO Screw Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 27.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.